Application of Nanotechnology in Organ Transplantation
DOI:
https://doi.org/10.54097/sb399121Keywords:
Nanotechnology, drug delivery system, medication.Abstract
Organ transplantation can serve as a blessing for end-stage organ patients, and issues such as organ shortage and transplantation risks also make research on organ transplantation very important. Nanotechnology involves the development of materials called nanoparticles, which are defined as having a one-dimensional range of at least 1 to 100 nm. This paper introduces the application of nanotechnology in overcoming the drawbacks of traditional medicine, and its nanoscale size has also contributed to organ transplantation. The combination of Magnetic resonance imaging (MRI) and Magnetic hyperthermia (MHT), nanoparticles can better capture transplant medical images, and nanotechnology plays an important role in monitoring treatment responses and designing organ transplantation methods. CRISPR/CAS9 system and Entrancerâ„¢ can reduce the role in rejection reactions. Normothermic Machine Perfusion (NMP), protein corona, and curcumin can reduce their effects on ischemia-reperfusion injury. The development of nanomedicine can provide a platform for significant progress in transplant vitality. In future research, nanoparticles can also be applied in 3D bioprinting and artificial intelligence (AI) to better assist in transplant therapy.
Downloads
References
Sreekala P., Suresh M., and Priyadarsini S.L. 3D organ printing: Review on operational challenges and constraints. Materials Today: Proceedings, 2019, 33: 4703-4707.
Zhao L., Seth A., Wibowo N., et al. Nanoparticle vaccines. Vaccine, 2014, 32: 327-337.
Kim M.J., and Lee D.Y. Application of nanomaterials for imaging pancreatic islets. Macromolecular Research, 2016, 24: 197-204.
Yao C.G., and Martins P.N. Nanotechnology applications in transplantation medicine. Transplantation, 2020, 104: 682-693.
Ochando J., and Braza M.S. Nanoparticle-based modulation and monitoring of antigen-presenting cells in organ transplantation. Frontiers in Immunology, 2017, 8: 1888.
Sharma A., Cressman E., Attaluri A., Kraitchman D.L., Ivkov R. Current challenges in image-guided magnetic hyperthermia therapy for liver cancer. Nanomaterials, 2022, 12: 2768.
Zhang Y. et al. In situ repurposing of dendritic cells with CRISPR/Cas9-based nanomedicine to induce transplant tolerance. Biomaterials, 2019, 217: 119302.
Qin Q. et al. Effects of CD25siRNA gene transfer on high-risk rat corneal graft rejection. Graefes Archive for Clinical and Experimental Ophthalmology, 2015, 253: 1765-1776.
Chen W.Y., and Li D.L. Reactive oxygen species (ROS)-responsive nanomedicine for solving ischemia-reperfusion injury. Frontiers in Chemistry, 2020, 8: 732.
Wang W. et al. Nanotechnology in kidney and islet transplantation: an ongoing, promising field. Frontiers in Immunology, 2020, 13.
Xu Y., Hu N., Jiang W., Yuan H.F., and Zheng D.H. Curcumin-carrying nanoparticles prevent ischemia-reperfusion injury in human renal cells. Oncotarget, 2016, 7: 87390-87401.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Highlights in Science, Engineering and Technology

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.







